Condition: Kidney Biopsy · Sponsor: Medical University of Bialystok
It is a randomized, multicenter, double-blind, placebo controlled, interventional clinical trial that will be conducted in Poland, in about 6 Hospital Nephrology Departments to evaluate the safety and effectiveness of desmopressin on the prevention of bleeding after percutaneous needle kidney biopsy in patients with rare and ultrarare glomerulonephritis.
This description comes directly from the study's public registry record.
Alicja Rydzewska-Rosołowska, Assoc.Prof. · +48 604 330 187 · alicja.rydzewska-rosolowska@umb.edu.pl
Always discuss trial participation with your own doctor first.
| II Department of Nephrology and Hypertension | Bialystok, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05467033